On April 15, the FDA published a notice scheduling a meeting of the Pharmacy Compounding Advisory Committee (PCAC) for July 2324, 2026, at which the committee will consider whether to recommend certain peptide bulk drug substances for inclusion on the 503A bulks list
For comprehensive anti-aging and skin repair, GHK-Cu offers broader benefits and is often used alongside other peptides for a multi-functional skincare approach
Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J, Yusuf S, Pocock S
People who struggle with nausea or vomiting on other treatments may tolerate Cagrilintide better